Announcements Trials
Browse Landscape

Phase

Phase 2 84Phase 1 54Phase 3 45Phase 1/2 31Phase 2/3 3Phase NA 2Phase EARLY_PHASE1 2Phase 4 2

Status

Withdrawn 3Terminated 2Recruiting 2Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23Metformin 14pembrolizumab 12Radiotherapy 12Biopsy 11Nivolumab 9Fluorouracil 9Cyclophosphamide 9Temozolomide 7Radiation 7Bevacizumab 7gallium 68 PSMA-11 6Sirolimus 6Rituximab 6Letrozole 6Etoposide 6Cisplatin 6Aspirin 6olaparib 5Surveys and Questionnaires 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Indocyanine Green 5Granulocyte Colony-Stimulating Factor 5Fluorodeoxyglucose F18 5Dexamethasone 5aldesleukin 4Surgical Procedures, Operative 4Proflavine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × atezolizumab × Clear all
NCT03802604 2025-09-09

PROMETEO

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed
28 enrolled
Breast

Breast Neoplasms

NCT02463994 2019-02-08

A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡